STABLE: protein-DNA fusion system for screening of combinatorial protein libraries in vitro.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMID 10471784)

Published in FEBS Lett on August 27, 1999

Authors

N Doi1, H Yanagawa

Author Affiliations

1: Mitsubishi Kasei Institute of Life Sciences, 11 Minamiooya, Machida, Tokyo, Japan.

Articles citing this

Highly stable and efficient mRNA templates for mRNA-protein fusions and C-terminally labeled proteins. Nucleic Acids Res (2003) 1.31

Specific bonding of puromycin to full-length protein at the C-terminus. Nucleic Acids Res (2000) 1.16

Nano-enabled synthetic biology. Mol Syst Biol (2007) 1.15

DNA display for in vitro selection of diverse peptide libraries. Nucleic Acids Res (2003) 1.12

PCR amplification from single DNA molecules on magnetic beads in emulsion: application for high-throughput screening of transcription factor targets. Nucleic Acids Res (2005) 1.07

Selection of ribozymes that catalyse multiple-turnover Diels-Alder cycloadditions by using in vitro compartmentalization. Proc Natl Acad Sci U S A (2005) 1.02

Directed evolution of streptavidin variants using in vitro compartmentalization. Chem Biol (2008) 1.00

Bicistronic DNA display for in vitro selection of Fab fragments. Nucleic Acids Res (2009) 0.91

In vitro selection of restriction endonucleases by in vitro compartmentalization. Nucleic Acids Res (2004) 0.90

Selection of a T7 promoter mutant with enhanced in vitro activity by a novel multi-copy bead display approach for in vitro evolution. Nucleic Acids Res (2012) 0.90

Random multi-recombinant PCR for the construction of combinatorial protein libraries. Nucleic Acids Res (2001) 0.89

A high-throughput screen for antibiotic drug discovery. Biotechnol Bioeng (2013) 0.86

An mRNA-protein fusion at N-terminus for evolutionary protein engineering. Int J Biol Sci (2007) 0.84

The outlook for protein engineering in crop improvement. Plant Physiol (2008) 0.81

Peptide aptamers: development and applications. Curr Top Med Chem (2015) 0.80

Directed evolution of anti-HER2 DARPins by SNAP display reveals stability/function trade-offs in the selection process. Protein Eng Des Sel (2015) 0.79

DNA display selection of peptide ligands for a full-length human G protein-coupled receptor on CHO-K1 cells. PLoS One (2012) 0.76

A Concept for Selection of Codon-Suppressor tRNAs Based on Read-Through Ribosome Display in an In Vitro Compartmentalized Cell-Free Translation System. J Nucleic Acids (2012) 0.76

Selection platforms for directed evolution in synthetic biology. Biochem Soc Trans (2016) 0.75

Use of cDNA tiling arrays for identifying protein interactions selected by in vitro display technologies. PLoS One (2008) 0.75

Stable mRNA-ribosome-polypeptide complexes and their use in functional screening of protein libraries. Dokl Biochem Biophys (2001) 0.75

Biomolecular engineering for nanobio/bionanotechnology. Nano Converg (2017) 0.75

Articles by these authors

(truncated to the top 100)

A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97

Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol (1999) 3.75

In vitro virus: bonding of mRNA bearing puromycin at the 3'-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro. FEBS Lett (1997) 2.40

Kawasaki disease in families. Pediatrics (1989) 1.83

Template-directed polymerization of oligoadenylates using cyanogen bromide. Biochemistry (1986) 1.60

Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset. Acta Paediatr (2002) 1.53

Association of alcohol intake, cigarette smoking, and occupational status with the risk of idiopathic osteonecrosis of the femoral head. Am J Epidemiol (1993) 1.39

Kawasaki disease in parents and children. Acta Paediatr (2003) 1.37

Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol (2000) 1.36

Fluorescence labeling of the C-terminus of proteins with a puromycin analogue in cell-free translation systems. FEBS Lett (1999) 1.27

Mortality among males in periodic-health-examination programs. N Engl J Med (1969) 1.27

Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86. Lancet (1986) 1.23

Physical-strength tests and mortality among visitors to health-promotion centers in Japan. J Clin Epidemiol (1995) 1.21

Long-term follow-up in sarcoidosis in Japan. Z Erkr Atmungsorgane (1977) 1.18

Specific bonding of puromycin to full-length protein at the C-terminus. Nucleic Acids Res (2000) 1.16

Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr (2001) 1.12

Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Pediatrics (1991) 1.10

Nationwide survey on Kawasaki disease in Japan. Pediatrics (1987) 1.09

Design of generic biosensors based on green fluorescent proteins with allosteric sites by directed evolution. FEBS Lett (1999) 1.08

[A method of interval estimation for number of patients in the nationwide epidemiological survey on intractable diseases]. Nihon Koshu Eisei Zasshi (1991) 1.03

A characteristic change in infant mortality rate decrease in Japan. Public Health (1991) 1.02

Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology. Brain Res (1996) 0.98

Epidemiology of infant Kawasaki disease with a report of the youngest neonatal case ever reported in Japan. Acta Paediatr (1996) 0.98

Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J Clin Invest (1994) 0.98

Surgical correction of the inverted nipple with a tendon graft: hammock procedure. Plast Reconstr Surg (1990) 0.97

Cardiac sequelae in recurrent cases of Kawasaki disease: a comparison between the initial episode of the disease and a recurrence in the same patients. Pediatrics (1998) 0.97

A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2-Hong Kong and B influenza viruses. J Infect Dis (1970) 0.96

Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice. Cancer Res (2000) 0.96

A possible prebiotic peptide formation from glycinamide and related compounds. Orig Life (1984) 0.95

Marine hydrothermal systems and the origin of life: future research. Orig Life Evol Biosph (1992) 0.95

Insertion of foreign random sequences of 120 amino acid residues into an active enzyme. FEBS Lett (1997) 0.95

Incidence rate of Creutzfeldt-Jakob disease in Japan. Int J Epidemiol (1999) 0.95

Trapezoid bone fracture. Ann Plast Surg (2000) 0.95

Solitary osteochondroma limiting flexion of the proximal interphalangeal joint in an infant: a case report. J Hand Surg Am (1992) 0.92

Asparagusate dehydrogenases and lipoyl dehydrogenase from asparagus mitochondria. Physical, chemical, and enzymatic properties. J Biol Chem (1976) 0.90

[Relationship between skipping breakfast and cardiovascular disease risk factors in the national nutrition survey data]. Nihon Koshu Eisei Zasshi (2001) 0.90

Cardiac sequelae of Kawasaki disease in Japan over 10 years. Acta Paediatr Jpn (1995) 0.90

T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages. J Immunol (1996) 0.90

Flushing pattern and idiopathic avascular necrosis of the femoral head. J Epidemiol (1996) 0.90

Random multi-recombinant PCR for the construction of combinatorial protein libraries. Nucleic Acids Res (2001) 0.89

Relationship between the level of activities of daily living and chronic medical conditions among the elderly. J Epidemiol (1998) 0.89

Serum sodium levels in patients with Kawasaki disease. Pediatr Cardiol (2005) 0.88

Insertional gene fusion technology. FEBS Lett (1999) 0.88

[Evaluation of a nationwide surveillance system for Kawasaki disease over an eleven-year period from 1984]. Nihon Koshu Eisei Zasshi (1996) 0.87

Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumour necrosis factor-alpha and interleukin-1. Eur Respir J (1992) 0.87

A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan. Eur J Pediatr (1996) 0.86

Mortality among persons with a history of Kawasaki disease in Japan: existence of cardiac sequelae elevated the mortality. J Epidemiol (2000) 0.86

[Validity of the infectious disease surveillance system on comparison of nationwide surveys of Kawasaki disease during a 10 year period]. Nihon Koshu Eisei Zasshi (2000) 0.86

Eosinophil colony-stimulating factor induced by administration of interleukin-2 into the pleural cavity of patients with malignant pleurisy. Am J Respir Cell Mol Biol (1990) 0.86

Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease. Acta Paediatr (1998) 0.86

Vascular involvement in benign infantile mitochondrial myopathy caused by reversible cytochrome c oxidase deficiency. Brain Dev (1997) 0.85

Serum C-reactive protein levels in patients with Kawasaki disease: from the results of nation-wide surveys of Kawasaki disease in Japan. Acta Paediatr (1997) 0.85

A case of pleomorphic adenoma of the lung with multiple distant metastases--observations on its oncogene and tumor suppressor gene expression. Anticancer Res (1998) 0.85

Immediate effects of a rucksack type orthosis on the elderly with decreased lumbar lordosis during standing and walking. Electromyogr Clin Neurophysiol (2008) 0.85

Mortality rates for patients with a history of Kawasaki disease in Japan. Kawasaki Disease Follow-up Group. J Pediatr (1996) 0.85

Secondary structural features of modules M2 and M3 of barnase in solution by NMR experiment and distance geometry calculation. Proteins (1993) 0.85

Foldability of barnase mutants obtained by permutation of modules or secondary structure units. J Mol Biol (1999) 0.85

Mortality among patients with a history of Kawasaki disease: the third look. The Kawasaki Disease Follow-up Group. Acta Paediatr Jpn (1998) 0.84

Epidemiological approach to SMON (subacute myelo-optico-neuropathy). Jpn J Med Sci Biol (1975) 0.84

[Geographic distribution of medical supplies and the numbers of hospital inpatients in the secondary medical areas in Japan]. Nihon Koshu Eisei Zasshi (1997) 0.83

Incidence rate of recurrent Kawasaki disease in Japan. Acta Paediatr (1994) 0.83

Genotype-phenotype linkage for directed evolution and screening of combinatorial protein libraries. Comb Chem High Throughput Screen (2001) 0.83

[A note on methods for estimating the number of patients in the nationwide epidemiological survey on intractable diseases]. Nihon Koshu Eisei Zasshi (1990) 0.83

Epidemic patterns of infectious diseases from the results of the surveillance of infectious diseases in Japan. Pediatr Infect Dis J (1988) 0.82

Protein anatomy: spontaneous formation of filamentous helical structures from the N-terminal module of barnase. Biochemistry (1993) 0.82

Estimation of the future numbers of patients with mental disorders in Japan based on the results of National Patient Surveys. J Epidemiol (1997) 0.82

Relationships between smoking habits and other behavior factors among males: from the results of the 1990 National Cardiovascular Survey in Japan. J Epidemiol (1996) 0.82

New modified method for the surgical treatment of syndactyly. Ann Plast Surg (1989) 0.82

Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan. Neurology (2000) 0.81

Factors related to cardiac sequelae of Kawasaki disease. Eur J Pediatr (1999) 0.81

A case-control study of Creutzfeldt-Jakob disease in Japan: transplantation of cadaveric dura mater was a risk factor. J Epidemiol (2000) 0.81

Interleukin-2-inducible killer activity and its regulation by blood monocytes from autologous lymphocytes of lung cancer patients. Jpn J Cancer Res (1991) 0.81

Statistical analyses on the pattern of food consumption and digestive-tract cancers in Japan. Nutr Cancer (1984) 0.81

Macrophage colony-stimulating factor activity in malignant pleural effusions. Its augmentation by intrapleural interleukin-2 infusions. Chest (1991) 0.81

Mortality among children with Kawasaki disease in Japan. N Engl J Med (1992) 0.81

Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing. J Leukoc Biol (1999) 0.80

Relationship of diet to the incidence of esophageal and stomach cancer in Japan. Nutr Cancer (1982) 0.80

Tumor cytotoxicity and interleukin 1 production of blood monocytes of lung cancer patients. Cancer Immunol Immunother (1990) 0.80

[Geographical distribution of medical expenditure for the aged insured by National Health Insurance in secondary medical care areas in Japan]. Nihon Koshu Eisei Zasshi (1998) 0.80

Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state. Int J Cancer (1988) 0.80

CD40 and IFN-gamma dependent T cell activation by human bronchial epithelial cells. J Med Invest (2001) 0.80

Formation of amino acid precursors in cometary ice environments by cosmic radiation. Adv Space Res (1995) 0.80

Relative risk of Creutzfeldt-Jakob disease with cadaveric dura transplantation in Japan. Neurology (1999) 0.80

[Epidemiologic study of admitted children with Kawasaki disease in Beijing from 1995 to 1999]. Zhonghua Yi Xue Za Zhi (2003) 0.80

Systemic chemotherapy alters interleukin-1 beta and its receptor antagonist production by human alveolar macrophages in lung cancer patients. Oncol Res (1996) 0.79

Hospital facilities available to patients with Kawasaki disease: results of a national survey of Kawasaki disease in Japan. Acta Paediatr Jpn (1996) 0.79

Origins of globular structure in proteins. FEBS Lett (1998) 0.79

Interleukin (IL-)15 has less activity than IL-2 to promote type 2 cytokine predominance in tumour-associated mononuclear cells from lung cancer patients. Cytokine (2001) 0.79

Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12. Int J Immunopharmacol (2000) 0.79

[Characteristics of medical institutions visited by patients with 26 intractable diseases who are residents of Saitama Prefecture (comparison of the data for 1984 and 1988)]. Nihon Eiseigaku Zasshi (1995) 0.79

Process and current status of the epidemiologic studies on cedar pollinosis in Japan. J Epidemiol (1999) 0.79

[Chronological trend of the incidence rate of Creutzfeldt-Jakob disease in Japan]. Nihon Eiseigaku Zasshi (1999) 0.78

Synthesis of polypeptides by microwave heating I. Formation of polypeptides during repeated hydration-dehydration cycles and their characterization. J Mol Evol (1990) 0.78

Characterization of random-sequence proteins displayed on the surface of Escherichia coli RNase HI. FEBS Lett (1998) 0.78

Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms. Jpn J Cancer Res (1996) 0.78

A multicenter collaborative study on the risk factors of cardiac sequelae due to Kawasaki disease: a one-year follow-up study. Acta Paediatr (2000) 0.78

Leukocyte counts in patients with Kawasaki disease: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr (1997) 0.78

Genesis of amino acids in the primeval sea. Formation of amino acids from sugars and ammonia in a modified sea medium. J Biochem (1980) 0.78

Successful treatment of metastatic cardiac lymphoma with complete A-V block. Anticancer Res (1998) 0.78

Spontaneous formation of helical structures from phospholipid-nucleoside conjugates. Biochemistry (1992) 0.78